| Obesity |
1 |
1 |
| Bariatric Surgery |
0 |
0.93 |
| Weight Loss |
0 |
0.99 |
| Weight Management |
0 |
0.98 |
| Adverse Effects |
0 |
0.47 |
| Patient Safety |
0 |
0.45 |
| Biliary Disease |
0 |
0.4 |
| Cardiovascular Risk Management |
0 |
0.37 |
| Lipids Management |
0 |
0.35 |
| Brain |
0 |
0.26 |
| Receptors |
0 |
0.26 |
| Thyroid Disease |
0 |
0.26 |
| Surgery |
0 |
0.21 |
| Head and Neck Cancer |
0 |
0.18 |
| Hypertension |
0 |
0.17 |
| Hemoglobin A1c |
0 |
0.15 |
| Biologic Therapy |
0 |
0.12 |
| Medullary Thyroid Cancer |
0 |
0.12 |
| Pain Management |
0 |
0.12 |
| Thyroid Cancer |
0 |
0.12 |
| Cardiometabolic Risk Factors |
0 |
0.11 |
| Fatty Liver |
0 |
0.11 |
| Genomic Medicine |
0 |
0.11 |
| Blood |
0 |
0.1 |
| Body Mass Index |
0 |
0.1 |
| Cancer |
0 |
0.1 |
| Diarrhea |
0 |
0.1 |
| Epidemic |
0 |
0.1 |
| Hemoglobin |
0 |
0.1 |
| Hypercholesterolemia |
0 |
0.1 |
| Liver |
0 |
0.1 |
| Medicare |
0 |
0.1 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.1 |
| Skeletal Myoblasts |
0 |
0.1 |
| Abdominal Infection |
0 |
0.09 |
| Abdominal Pain |
0 |
0.09 |
| Pancreatitis |
0 |
0.09 |
| Abdomen |
0 |
0.05 |
| Acute Pancreatitis |
0 |
0.05 |
| Adolescent Medicine |
0 |
0.05 |
| Alzheimer Disease |
0 |
0.05 |
| Botox |
0 |
0.05 |
| Cannabinoids |
0 |
0.05 |
| Cardiovascular disease |
0 |
0.05 |
| Child |
0 |
0.05 |
| Constipation |
0 |
0.05 |
| Depression |
0 |
0.05 |
| Drug Development |
0 |
0.05 |
| Endocannabinoids |
0 |
0.05 |
| Erectile Dysfunction |
0 |
0.05 |
| Femoral |
0 |
0.05 |
| Financial Reimbursement |
0 |
0.05 |
| Gallstone |
0 |
0.05 |
| Gastric Bypass |
0 |
0.05 |
| Gene Therapy |
0 |
0.05 |
| Generics |
0 |
0.05 |
| Geriatrics |
0 |
0.05 |
| Health Care Economics |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Hemophilia |
0 |
0.05 |
| Hemophilia A |
0 |
0.05 |
| Hyperlipidemia |
0 |
0.05 |
| Incretin Hormone |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| LDL Cholesterol |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Molecular Medicine |
0 |
0.05 |
| Multiple Endocrine Neoplasia (MEN) |
0 |
0.05 |
| Muscle |
0 |
0.05 |
| Nausea |
0 |
0.05 |
| Osteoarthritis |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Pancreas |
0 |
0.05 |
| PCSK9 |
0 |
0.05 |
| Rare Diseases |
0 |
0.05 |
| Skeletal |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |
| Stomach |
0 |
0.05 |
| Thyroid |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Translational Research |
0 |
0.05 |
| Triglycerides |
0 |
0.05 |
| Tumor |
0 |
0.05 |
| Type 2 Diabetes Mellitus |
0 |
0.05 |
| Viagra |
0 |
0.05 |